These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31655215)

  • 1. Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study.
    Daneman N; Chateau D; Dahl M; Zhang J; Fisher A; Sketris IS; Quail J; Marra F; Ernst P; Bugden S;
    Clin Microbiol Infect; 2020 May; 26(5):613-618. PubMed ID: 31655215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current prescribing practices and guideline concordance for the treatment of uncomplicated urinary tract infections in women.
    Langner JL; Chiang KF; Stafford RS
    Am J Obstet Gynecol; 2021 Sep; 225(3):272.e1-272.e11. PubMed ID: 33848538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional variation in the potentially inappropriate first-line use of fluoroquinolones in Canada as a key to antibiotic stewardship? A drug utilization review study.
    St-Jean A; Chateau D; Dahl M; Ernst P; Daneman N; Sketris IS; Zhang J; Marra F; Quail J; Bugden S;
    BMC Infect Dis; 2021 Aug; 21(1):733. PubMed ID: 34344348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning.
    Bratsman A; Mathias K; Laubscher R; Grigoryan L; Rose S
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):701-707. PubMed ID: 32390266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.
    Cowart K; Worley M; Rouby NE; Sando K
    Ann Pharmacother; 2019 Dec; 53(12):1192-1199. PubMed ID: 31319681
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study.
    Ernst P; Dahl M; Chateau D; Daneman N; Quail J; Sketris IS; Fisher A; Zhang J; Bugden S;
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2939-2946. PubMed ID: 31908442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for Systemic Fluoroquinolone Therapy in Europe and Prevalence of Primary-Care Prescribing in France, Germany and the UK: Descriptive Population-Based Study.
    Morales DR; Slattery J; Pinheiro L; Kurz X; Hedenmalm K
    Clin Drug Investig; 2018 Oct; 38(10):927-933. PubMed ID: 30143952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration.
    Sankar A; Swanson KM; Zhou J; Jena AB; Ross JS; Shah ND; Karaca-Mandic P
    JAMA Netw Open; 2021 Dec; 4(12):e2136662. PubMed ID: 34851398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli.
    Rattanaumpawan P; Nachamkin I; Bilker WB; Roy JA; Metlay JP; Zaoutis TE; Lautenbach E;
    Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):25. PubMed ID: 28390438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral beta-lactam step down in bacteremic E. coli urinary tract infections.
    Saad S; Mina N; Lee C; Afra K
    BMC Infect Dis; 2020 Oct; 20(1):785. PubMed ID: 33087051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High risk of Clostridium difficile infection among spinal cord injured patients after the use of antibiotics commonly used to treat urinary tract infections.
    Liu B; Reid J; Silverman M; Welk B
    Neurourol Urodyn; 2020 Nov; 39(8):2401-2408. PubMed ID: 32902908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fosfomycin for Antibiotic Prophylaxis in Men Undergoing a Transrectal Prostate Biopsy: A Systematic Review and Meta-Analysis.
    Gu HM; Gu JS; Chung HS; Jung SI; Kwon D; Kim MH; Jung JH; Han MA; Kang SJ; Hwang EC; Dahm P
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241143
    [No Abstract]   [Full Text] [Related]  

  • 13. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National trends in emergency department antibiotic prescribing for elders with urinary tract infection, 1996-2005.
    Caterino JM; Weed SG; Espinola JA; Camargo CA
    Acad Emerg Med; 2009 Jun; 16(6):500-7. PubMed ID: 19245373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection.
    Gopalakrishnan C; Bykov K; Fischer MA; Connolly JG; Gagne JJ; Fralick M
    JAMA Intern Med; 2020 Dec; 180(12):1596-1605. PubMed ID: 32897307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of antibiotic treatment failure in premenopausal women with uncomplicated urinary tract infection.
    Butler AM; Durkin MJ; Keller MR; Ma Y; Dharnidharka VR; Powderly WG; Olsen MA
    Pharmacoepidemiol Drug Saf; 2021 Oct; 30(10):1360-1370. PubMed ID: 33783918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option.
    Blondeau JM
    Drugs; 2004; 64(6):611-28. PubMed ID: 15018591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient Fluoroquinolone Use in Children, 2000-2018.
    Ross RK; Gerber JS; Willis ZI; Hersh AL; Kinlaw AC
    J Pediatric Infect Dis Soc; 2021 May; 10(5):576-585. PubMed ID: 33377490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic Use in Hospital Urinary Tract Infections After FDA Regulation.
    Brant A; Lewicki P; Wu X; Sze C; Johnson JP; Ponsky L; Kaye KS; Wise GJ; Shoag JE
    J Gen Intern Med; 2024 Jun; 39(8):1414-1422. PubMed ID: 38148474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of fluoroquinolones in the management of urinary tract infections in areas with high rates of fluoroquinolone-resistant uropathogens.
    Chen YH; Ko WC; Hsueh PR
    Eur J Clin Microbiol Infect Dis; 2012 Aug; 31(8):1699-704. PubMed ID: 22052606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.